ELFN1 is a new extracellular matrix (ECM)-associated protein

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Elfin-1 (ELFN1) is a transmembrane protein primarily studied in the central nervous system as a binding partner for metabotropic glutamate receptors (mGluRs).
• ELFN1 deficiency is linked to neurological and neuropsychiatric disorders.
• Recent findings suggest ELFN1 may also play a role in connective tissues, indicated by severe joint laxity in patients with ELFN1 mutations.

Purpose of the Study:

• To investigate the extracellular matrix (ECM)-related functions of Elfin-1 (ELFN1).
• To explore the impact of ELFN1 mutations on fibroblast behavior and ECM interactions.

Main Methods:

• Isolation of primary skin fibroblasts from patients with ELFN1 mutations and healthy donors.
• Development and analysis of in vitro extracellular matrix (ECM) and decellularized ECM (dECM) models using these fibroblasts.

Main Results:

• ELFN1 mutations in the signal peptide region lead to a significant reduction in ELFN1 expression.
• Fibroblast morphology, growth, proliferation, and motility were markedly altered in ELFN1-deficient cells.
• The extracellular matrix (ECM) properties, including stiffness, were affected by ELFN1 deficiency.

Conclusions:

• Elfin-1 (ELFN1) plays a role in cell-extracellular matrix (ECM) attachment.
• ELFN1 deficiency impairs cell motility and reduces ECM stiffness.
• These findings highlight a novel function of ELFN1 in connective tissue biology beyond its known role in the nervous system.